January 2025 Prescription Drug Affordability Board Meeting
- Date and time: January 27th, 2025 2:00 pm
Public Comment
The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected] no later than the close of business on Wednesday, January 22, 2025, and provide:
- Your name
- Your address
- The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.
Written Comment
The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please submit any written comments, concerning this agenda no later than the close of business on Wednesday, January 22, 2025. Please utilize the subject line “January 2025 Board Comments.”
Cost Review Study Process
The Board invites public comment concerning Farxiga and Jardiance in connection with the cost review study. Under COMAR 14.01.04.05D, the Board may consider oral public comment made at the Board meeting, and written comments.
- If you wish to provide an oral comment at the January 27, 2025 meeting, please register to speak, at least 2 work days before the scheduled meeting (by Wednesday, January 22, 2025), in accordance with COMAR 14.01.01.05A. To register, please email [email protected] and provide
- Your name
- Your address
- The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.
- If you wish to provide written comments, please submit any comments and materials to [email protected], at least 2 work days before the scheduled meeting (by Wednesday, January 22, 2025), in accordance with COMAR 14.01.01.05B.
Agenda and Meeting Materials
- Agenda (Revised 1/22/2025) - PDF - 157.22 KB
- Minutes- Corrected - PDF - 95.71 KB
- Meeting Recording
- Final Action- Amendments to COMAR 14.01.04.05 Cost Review Study- Presentation - PDF - 155.55 KB
- Final Action- Amendments to COMAR 14.01.04.05 Cost Review Study - PDF - 155.69 KB
- Written Comment Packet - PDF - 643.53 KB
Comments Received from the following entities:
- EACH/PIC Coalition and Public Citizen